Navigation Links
Palkion Selects Novel Oral Development Candidate for the Treatment of Anemia
Date:6/29/2009

SAN DIEGO, June 29 /PRNewswire/ -- Palkion, Inc. announced today that it has initiated preclinical development studies for its orally available anemia therapeutic candidate that modulates the Hypoxia-Inducible Factor Prolyl Hydroxylase (HIF-PH) enzyme system. In February 2008, Palkion was founded when a novel drug discovery and development firm, CrystalGenomics (KOSDAQ: CRYSTAL [A083790]) and a leading US-based venture capital firm, ProQuest Investments, formed a new joint venture entity.

Under this strategic alliance, CrystalGenomics is receiving upfront and research funding for 2 years from Palkion, in addition to development and sales milestone payments of potentially more than US$200 million. CrystalGenomics' role is to use its unique structure-based drug discovery platform to identify novel drug candidates while Palkion oversees the clinical development.

Since the start of this agreement, CrystalGenomics has placed a high priority on this project leading to faster delivery of preclinical candidates than originally expected. Palkion and CrystalGenomics anticipate the initiation of safety and efficacy clinical studies in 2010. There is a high level of enthusiasm as Palkion's candidates have demonstrated benefits and features in terms of efficacy at this early stage of development. In preparation of expedited preclinical development, Palkion has been assembling a team of clinical, regulatory and commercial experts from the pharmaceutical industry.

There is a great market opportunity for anemia therapeutics as IMS Health reported that Erythropoietins such as Aranesp(R), Epogen(R), and Procrit(R), ranked as the #5 top-selling therapeutic classes in the U.S. for 2006 with total sales of US$10 billion. However, since all of these currently available Erythropoietins are injectables, an oral agent, as being developed by Palkion, could be very appealing from both a commercial and clinical perspective as an ora
'/>"/>

SOURCE Palkion, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service
2. HybridSPE(TM)-Precipitation Technology Wins SelectScience.net 2009 Scientists Choice Award for Best New Separations Product in 2008
3. Gemin X Pharmaceuticals Selects and Deploys Clinical Force CTMS
4. The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
5. VeraSun Energy Selects Valero as Successful Bidder for Seven Facilities
6. USAID Selects Abt Associates to Lead Team in Strengthening Mexico Private Sector Competitiveness
7. The Australian Research Council Selects Scopus for the Evaluation of the Australian Research Landscape
8. Cleveland Clinic Selects Laparoendoscopic Single-Site Surgery (LESS) as One of the Top Ten Innovations of 2009
9. The IN VIVO Blog Selects First Annual Deal of the Year
10. Tully-Wihr Company Selects Web-Based Allscripts Electronic Health Record for 100 Northern California Physicians
11. WuXi AppTec Selects H-Cube from ThalesNano for Laboratory-based Hydrogenation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... (PRWEB) May 21, 2013 Alpha ... distributor , will be exhibiting for the 13th ... of Medical Instrumentation (AAMI) 2013 Conference and Expo. ... support, distribute, and manufacture healthcare technologies. This year’s ... Long Beach, California. , The three-day event ...
(Date:5/21/2013)... , May 21, 2013 The ... and Transplant Association) is the biggest congress in ... therapy. Nearly 10,000 participants are in Istanbul ... latest research findings. New pioneering studies have been presented: ... FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ESA USE" ...
(Date:5/21/2013)... Savoury Systems International (SSI), a leader ... to Southeastern USA Sales Broker. Braddy’s new role will ... the Southeast. , In 2004 Braddy founded ... to food processors and industrial manufacturers. Braddy has ... industry and has over 25 years of sales management ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 ... services company for clinical trials, announced today it ... Solutions, LLC. Clinverse’s ClinPay® FLS eClinical commerce ... payment process. SpendMD ™, Aggregate Spend ... solution for tracking and reporting transfer of value ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3
... ago, entrepreneurs Nathan Lustig and John Tucker were still in ... the University of Wisconsin-Madison . , ,But graduate student ... saw students regularly selling used books back to the bookstore ... an opportunity to cut out the middleman. , ,So ...
... Wis. - The recent decision by a young researcher ... some of the financial consequences of the same-sex union debate ... and nanotechnology researcher, has won $3.4 million in grants since ... year, he will take his knowledge and research with him ...
... Wis. - Imago Scientific Instrument Corp. , ... an upgrade to its main product line. , ,Imago ... of atoms, to research facilities in the semiconductor, data ... offer key insights into how a material's properties are ...
Cached Biology Technology:Website targets college students nationwide 2Website targets college students nationwide 3Website targets college students nationwide 4Departure of nanotech researcher stings UW 2Departure of nanotech researcher stings UW 3
(Date:5/21/2013)... RICHLAND, Wash. A new analysis shows that the ... growth of enough algae to produce up to 25 ... United States, one-twelfth of the country,s yearly needs. , ... water resources that would be needed to grow significant ... The results were published in the May 7 issue ...
(Date:5/21/2013)... occur in the body, stem cells in the ... differentiating into mature immune cells that can fight ... deplete these cell populations, potentially leading to the ... Now, a team of researchers led by biologists ... found that, in mouse models, the molecule microRNA-146a ...
(Date:5/21/2013)... class of pharmaceuticals can both prevent and treat Alzheimer,s ... "TSPO ligands," are currently used for certain types of ... ligand in young adult mice when pathology was at ... was quite severe," said lead researcher Christian Pike of ... measures of pathology and improved behavior at both ages." ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4Keeping stem cells strong 2Drugs found to both prevent and treat Alzheimer's disease in mice 2
... become invaluable decision-making tools for public health officials. ... of 2001, models can be useful in two ... an infection and they can allow the comparison ... make implicit assumptions that may systematically bias their ...
... have enhanced the abilities of the molecules they are ... man-made molecular complexes enter cancer cells and, when signaled, ... The new supermolecules have more units that will absorb ... light frequencies that can be included and excluded as ...
... disease from HIV and hepatitis is increasing in the United ... surgery. Now, researchers have shown that nearly 40 percent of ... tested positive for a bloodborne germ. , "While these rates ... been in effect for some time to prevent the spread ...
Cached Biology News:Field of beams - Novel system uses polarized light pulses to reveal crop health 2Virginia Tech group adds tools to DNA-targeted anti-cancer drugs 2Virginia Tech group adds tools to DNA-targeted anti-cancer drugs 3Scalpel-free surgery could reduce risk of HIV and hepatitis exposure for health care workers 2
Request Info...
Mouse monoclonal [3G131] to Desmoglein 1 ( Abpromise for all tested applications). entrezGeneID: 1828 SwissProtID: Q02413...
TCP-1 alpha (H-110)...
Synphilin 1 Immunogen: Synthetic peptide corresponding to residues S(829) L E L N G E K D K D K G R T L Q R T(847) of human Synphilin 1. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: